-transparent.png){kind=logo}
Following oral administration of DL-[14C]prenylamine, about 40% of the dose administered was excreted in urine within 10 days. Less than 0.1% of the dose was excreted as unchanged prenylamine. The drug was extensively metabolized to at least 20 to 25 metabolites. The structure of 12 metabolites could be elucidated by means of g.c.m.s. Ring hydroxylation and further methylation of the phenolic metabolites are the main metabolic pathways involved. A substantial part of the drug and/or its metabolites is metabolized via cleavage of the C--N--C bond, giving rise to amphetamine and diphenylpropylamine which are further metabolized by aromatic and sidechain hydroxylation.
Related Publications
G Remberg, and
M Eichelbaum, and
G Spiteller, and
H J Dengler
August 1955,
Biochimica et biophysica acta,
G Remberg, and
M Eichelbaum, and
G Spiteller, and
H J Dengler
December 1961,
Biochimica et biophysica acta,
G Remberg, and
M Eichelbaum, and
G Spiteller, and
H J Dengler
December 1968,
The Journal of endocrinology,
G Remberg, and
M Eichelbaum, and
G Spiteller, and
H J Dengler
April 1982,
The Journal of pharmacy and pharmacology,
G Remberg, and
M Eichelbaum, and
G Spiteller, and
H J Dengler
June 1967,
The American journal of physiology,
G Remberg, and
M Eichelbaum, and
G Spiteller, and
H J Dengler
September 1953,
The Biochemical journal,
G Remberg, and
M Eichelbaum, and
G Spiteller, and
H J Dengler
July 1964,
The Journal of biological chemistry,
G Remberg, and
M Eichelbaum, and
G Spiteller, and
H J Dengler
May 1982,
Xenobiotica; the fate of foreign compounds in biological systems,
G Remberg, and
M Eichelbaum, and
G Spiteller, and
H J Dengler
October 1968,
The Journal of endocrinology,
G Remberg, and
M Eichelbaum, and
G Spiteller, and
H J Dengler
June 1977,
British journal of anaesthesia,
